JR

Jack A. Roth

University Of Texas System: 34 patents #12 of 6,559Top 1%
US US Dept of Health & Human Services: 2 patents #591 of 3,044Top 20%
RL Rhone-Poulenc Rorer Limited: 1 patents #42 of 79Top 55%
UT University Of Texas: 1 patents #37 of 278Top 15%
TR The Universty Of Texas System,Board Of Regents: 1 patents #10 of 109Top 10%
UR University Of Texas, Board Of Regents: 1 patents #4 of 21Top 20%
EI Enterprises International: 1 patents #25 of 36Top 70%
IT Introgen Therapeutics: 1 patents #8 of 12Top 70%
📍 Houston, TX: #334 of 21,073 inventorsTop 2%
🗺 Texas: #2,595 of 125,132 inventorsTop 3%
Overall (All Time): #82,535 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 1–25 of 39 patents

Patent #TitleCo-InventorsDate
11278592 Methods and compositions for TUSC2 immunotherapy Lin Ji 2022-03-22
10293056 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases Rajagopal Ramesh, Tomoyuki Saeki, Deborah R. Wilson 2019-05-21
9944951 Chromosome 3p21.3 genes are tumor suppressors Lin Ji, John Minna, Michael Lerman 2018-04-17
9675663 TUSC2 therapies David Stewart, Charles LU, Ignacio I. WISTUBA, Shaoyu YAN, Maria I. NUNEZ 2017-06-13
8859727 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes Jacki Lin, Ralph B. Arlinghaus, Tong Sun, Lin Ji, Bulent Ozpolat +1 more 2014-10-14
8658778 hTMC promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes Lin Ji, Bingliang Fang 2014-02-25
8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes Jacki Lin, Ralph B. Arlinghaus, Tong Sun, Lin Ji, Bulent Ozpolat +1 more 2012-12-25
7977468 Chromosome 3p21.3 genes are tumor suppressors Lin Ji, John Minna, Michael Lerman 2011-07-12
7902441 Chromosome 3p21.3 genes are tumor suppressors Lin Ji, John Minna, Michael Lerman 2011-03-08
7423015 Antihelminthic drugs as a treatment for hyperproliferative diseases Tapas Mukhopadhyay, Sunil Chada, Abner Mhashilkar 2008-09-09
7252989 Adenovirus supervector system Wei Zhang 2007-08-07
7244617 Diminishing viral gene expression by promoter replacement Bingliang Fang 2007-07-17
7163925 p16 expression constructs and their application in cancer therapy Xiaomei Jin 2007-01-16
7109179 Methods and compositions comprising DNA damaging agents and p53 Toshiyoshi Fujiwara, Elizabeth A. Grimm, Tapas Mukhopadhyay, Wei Zhang, Laurie B. Owen-Schaub 2006-09-19
7033750 Recombinant P53 adenovirus methods and compositions Wei Zhang 2006-04-25
6998117 Cancer treatment with retroviral vectors comprising wild-type p53 Tapas Mukhopadhyay, Michael Tainsky 2006-02-14
6905873 Recombinant p53 adenovirus methods and compositions Wei Zhang 2005-06-14
6899870 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery Timothy J McDonnell, Stephen Swisher, Bingliang Fang, Elizabeth Bruckheimer, Mona G. Sarkiss +1 more 2005-05-31
6830749 Recombinant P53 adenovirus methods and compositions Wei Zhang 2004-12-14
6805858 Methods for the administration of adenovirus p53 Wei Zhang 2004-10-19
6797702 Methods and compositions comprising DNA damaging agents and P53 Toshiyoshi Fujiwara, Elizabeth A. Grimm, Tapas Mukhopadhyay, Wei Zhang, Laurie B. Owen-Schaub 2004-09-28
6740320 Recombinant P53 adenovirus methods and compositions Wei Zhang 2004-05-25
6630344 Diminishing viral gene expression by promoter replacement Bingliang Fang 2003-10-07
6627189 Inhibition of cellular proliferation using ras antisense molecules Tapas Mukopadhyay, Michael Tainsky 2003-09-30
6511847 Recombinant p53 adenovirus methods and compositions Wei Zhang 2003-01-28